NCT01275053View on ClinicalTrials.gov

In Vivo Leptin Signaling in Humans After Acute Leptin Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2017

Conditions
LeanObeseObese Diabetics
Interventions
DRUG

leptin

0.01mg/kg

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01275053 - In Vivo Leptin Signaling in Humans After Acute Leptin Administration | Biotech Hunter | Biotech Hunter